盐酸缬更昔洛韦片怎么买呢？

In May 2001, it was approved by the US FDA for clinical use in the treatment of acute retinitis caused by CMV infection in patients with acquired immunodeficiency syndrome. In May 2003, its indications were expanded. Valganciclovir hydrochloride tablets are used to prevent and treat secondary CMV infection in organ transplant recipients. On August 11, 2010, Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) approved valganciclovir hydrochloride tablets for the treatment of adult kidney transplant patients at high risk for cytomegalovirus (CMV) disease.

Valganciclovir hydrochloride tablets are well absorbed from the gastrointestinal tract and rapidly metabolized into ganciclovir in the small intestinal wall and liver. The absolute bioavailability of ganciclovir converted from valganciclovir is approximately 60%. The systemic exposure of valganciclovir hydrochloride tablets is small and transient. The 24-hour area under the curve AUC24 and peak concentration (Cmax) are only 1% and 3% of ganciclovir respectively.

How to buy Valganciclovir Hydrochloride Tablets?

As early as 2006, valganciclovir hydrochloride tablets were launched in China and are suitable for the treatment of patients with acquired immunodeficiency syndrome (AIDS) combined with cytomegalovirus (CMV) retinitis, as well as the prevention of CMV infection in high-risk solid organ transplant patients.

It is relatively convenient to buy in China, and you can basically buy it in regular domestic pharmacies. However, domestic valganciclovir hydrochloride tablets are original drugs and are relatively expensive. The specification is 450mg/60 tablets/box, and the price is about RMB 16,500. Roche's Valgancilovir (valgancilovir hydrochloride tablets, 450mg*60 tablets) sells for about RMB 5,500 in Indian pharmacies. Patients can purchase them in person or through Medical Companion Travel.